Viralgen and Trogenix to progress gene therapy for glioblastoma
The partnership has enabled Viralgen to scale up and complete a GMP trial material batch of Trogenix's therapy.
Cytiva Navigating cell therapy WP 4
Entering the era of prenatal gene therapies
Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
DAAN Biotherapeutics and GC Cell partner for CAR-T, CAR-NK therapies
Allogeneic cell therapies “poised for prime time” says expert
EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
Unsafe and unregulated cell therapies being sold in Europe
